McKesson Corporation (NYSE:MCK) Files An 8-K Regulation FD Disclosure
Item7.01
| Regulation FD Disclosure. |
On May18, 2017, McKesson Corporation (the Company) posted to its
website supplemental recast financial information for fiscal year
ended March31, 2017 and fiscal quarters ended June30, 2016,
September30, 2016, December31, 2016 and March31, 2017 for its
amended definition of Adjusted Earnings (Non-GAAP). From the main
page of the Companys website, the posted material can be located
under the Investors tab.
The information contained in this Form 8-K, including Exhibit
99.1, is furnished to the Securities and Exchange Commission (the
Commission), but shall not be deemed filed with the Commission
for purposes of Section18 of the Securities Exchange Act of 1934,
as amended (the Exchange Act), or incorporated by reference in
any filing under the Securities Act of 1933, as amended, or the
Exchange Act except as shall be expressly set forth by specific
reference in such a filing.
| Item9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits. |
|
ExhibitNo. |
Description |
|
| 99.1 |
Supplemental recast financial information as posted to the Companys website on May18, 2017. |
About McKesson Corporation (NYSE:MCK)
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology. McKesson Corporation (NYSE:MCK) Recent Trading Information
McKesson Corporation (NYSE:MCK) closed its last trading session down -0.60 at 141.44 with 1,822,981 shares trading hands.
